Portman Square Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Sell
94,800
-5,200
-5% -$566K 0.67% 43
2026
Q1
$9.24M Buy
+100,000
New +$10M 0.36% 66
2023
Q2
Sell
-31,000
Closed -$727K 415
2023
Q1
$727K Hold
31,000
0.03% 230
2022
Q4
$843K Buy
+31,000
New +$1.42M 0.06% 210

Other funds holding GH

Portman Square Capital's GH Position: Q1 2024 in Review

Portman Square Capital sold out of Guardant Health (GH) in Q1 2024, closing a stake of 9,474 shares — an estimated $256K sold.

Portman Square Capital first reported a position in GH in Q2 2023 and held it in 3 quarters. The position peaked at $1.48M in Q2 2023. 257 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Portman Square Capital reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • Portman Square Capital sold 9,474 Guardant Health shares in Q1 2024, an estimated $256K.
  • Portman Square Capital first reported a position in Guardant Health in Q2 2023 and held it in 3 quarters.
  • Portman Square Capital's Guardant Health position peaked at $1.48M in Q2 2023.
  • 257 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Portman Square Capital's 13F filing for Q1 2024, filed 15 Apr 2024.